Loading clinical trials...

COMPLETEDPhase 2NCT00752505

A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.

The study is designed to assess if esreboxetine can improve the cognitive function of patients with fibromyalgia. Cognitive function is defined as the ability to concentrate, remember things and make ...

Lead sponsor: Pfizer•7 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

NCT07226648 · Fibromyalgia

RECRUITING

The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor

NCT07358754 · Fibromyalgia

RECRUITING

Assessing Central Aspects of Pain

NCT06518278 · Osteoarthritis, Fibromyalgia, and more

RECRUITINGNA

Exercise Interventions and Dietary Advice in Fibromyalgia and IBS

NCT06923800 · Fibromyalgia, Irritable Bowel Syndrome

RECRUITINGNA

Autoimmune Intervention Mastery Course Study

NCT05057676 · Multiple Sclerosis, Clinically Isolated Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 4, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment89

Start dateAug 2008

Last updatedDec 4, 2018

Condition

Fibromyalgia

Locations shown

Pfizer Investigational Site

Destin, Florida

Pfizer Investigational Site

Fort Walton Beach, Florida

Pfizer Investigational Site

Ann Arbor, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 4, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor

Assessing Central Aspects of Pain

Exercise Interventions and Dietary Advice in Fibromyalgia and IBS

Autoimmune Intervention Mastery Course Study

Trial snapshot

Condition

Locations shown

For caregivers